Press release
Ongoing Study Offers Key Foresights on Expansion of Retinal Drugs And Biologics Market During 2017 - 2027
Retina is a very sensitive and delicate part of human eye which is responsible for receiving and processing light to convert into neural signals and send to the brain for visual activity. The disorders related to retinal health include age-related macular degeneration, diabetic retinopathy, infectious retinitis, macular edema, macular hole, retinoblastoma, retinal degeneration, retinoschisis and uveitis etc. There are various types of retinal disorders but most of them cause visual symptoms. For instance, age-related macular degeneration (AMD), the most common retinal disease is associated with aging. It is a leading cause of blindness among people over the age of 50. Diabetic retinopathy is another major retinal disease which is a result of complications of diabetes. Diabetes damage the tiny blood vessels of retina and blood or fluids start to leak out from the vessels. The treatment of retinal disorders include surgery and medicines.Request For Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-4055
Retinal Drugs and Biologics Market: Drivers and Restraints
The key contributor to the growth of global retinal drugs and biologics market is globally rising incidences of ophthalmic disorders related to age. Emergence of various innovative products in forms of biologics and drug releasing implants as a result of research and development and continuous efforts to invent treatment alternatives are contributing to the market growth. Introduction of biologics such as Lucentis to the ophthalmology field has represented a true paradigm shift in the treatment of patients. Lucentis has been successful in preserving vision in 90% of wet age related macular degeneration. However, the availability of limited number of biologics, severe side effects of biologics, strict regulatory norms associated with the approval of biologics, inaccessibility to the effective drugs and biologics due to high costs may limit the market growth.
Retinal Drugs and Biologics Market: Segmentation
Global retinal drugs and biologics market has been segmented on the basis of types of conditions, types of therapies, distribution channels and region.
Based on types of conditions, the global retinal drugs and biologics market is segmented into:
Age related macular degeneration
Diabetic retinopathy
Ocular Inflammatory Disease (Uveitis)
Macular Hole
Based on the types of therapies, the global retinal drugs and biologics market is segmented into:
Surgery
Medicines
Intravitreal Injections
Medicines
Anti-VEGF Drugs
Ranibizumab
Bevacizumab
Aflibercept
Intravitreal Implant Releasing Steroids
Dexamethasone
Fluocinolone
Retinal Laser
Based on the distribution channels, the global Retinal Drugs and Biologics Market is segmented into:
Retail Pharmacies
Hospital Pharmacies
Specialty Ophthalmology Clinics
Retinal Drugs and Biologics Market: Overview
Global Retinal Drugs and Biologics market is highly fragmented with the presence of multiple players.Overall market is expected to report a sound growth as the epidemiologic studies have revealed that over 296 million people suffer from some type of retinal disease or condition globally, around 142 million people across the globe are impacted by age-related macular degeneration and approximately 105 million are affected by diabetic eye disease, these two diseases in combination are leading causes of vision loss globally.
Retinal Drugs and Biologics Market: Region-wise Outlook
Geographically, Retinal Drugs and Biologics Market is segmented into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, Middle East and Africa. European countries have been witnessed highest incidence rates in case of retinal disorders followed by North America. The incidence rates of retinal diseases in Asia Pacific countries is comparatively less but it is increasing gradually, hence the market will show a gradual increase in this region. Diabetes also plays a significant role in retinal disease treatment market. The growing incidence rate of diabetes in developed countries due to sedentary life style and unhealthy habits is expected to fuel the market growth for retinal diseases drugs and biologics.
Request For Report Table of Content (TOC): https://www.futuremarketinsights.com/toc/rep-gb-4055
Retinal Drugs and Biologics Market: Key Players
Some of the players active in the global Retinal Drugs and Biologics Market include ALLERGAN, Alimera Sciences, AbbVie Inc., Janssen Biotech, Inc., Swedish Orphan Biovitrum, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Genzyme Corporation, Genentech USA, Inc., OCULAR THERAPEUTIX, INC. and Bausch & Lomb Incorporated and UCBCares.
About Us
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.
FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.
U.S. Office
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Web: https://www.futuremarketinsights.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ongoing Study Offers Key Foresights on Expansion of Retinal Drugs And Biologics Market During 2017 - 2027 here
News-ID: 1269575 • Views: …
More Releases from Future Market Insights

Global Anesthesia Equipment Market to Reach USD 18.2 Billion by 2035
The Anesthesia Equipment Market is witnessing robust growth, with its value estimated at USD 9.3 billion in 2025 and projected to nearly double to USD 18.2 billion by 2035. This growth trajectory represents a compound annual growth rate of 7.0%, driven by increasing surgical volumes, rising prevalence of chronic respiratory and cardiovascular disorders, and ongoing expansion of healthcare infrastructure. The market is undergoing transformative change, as both established manufacturers and…

Intravascular Ultrasound Systems Market to Reach USD 1455.7 Million by 2035
The intravascular ultrasound (IVUS) systems market is on track to record consistent growth over the next decade. Valued at USD 893.7 million in 2025, the market is expected to expand to USD 1455.7 million by 2035, reflecting a compound annual growth rate of 5.0%. With cardiovascular disease remaining one of the leading causes of mortality globally, the demand for advanced intravascular imaging technologies is escalating. IVUS systems, which provide real-time…

Electric Power Sports Market to Reach USD 18.5 Billion by 2035
The global Electric Power Sports Market is on a fast track to transformation, as consumers, manufacturers, and policymakers align on one powerful goal: sustainable, high-performance recreational experiences. Valued at USD 10.3 billion in 2025, the market is projected to expand to USD 18.5 billion by 2035, reflecting a steady compound annual growth rate (CAGR) of 6.0%.
This momentum is set to generate an absolute dollar opportunity of USD 8.2 billion over…

Hair Straightener Market Forecast to Reach USD 12.4 Billion by 2035 as Innovatio …
The global hair straightener market is entering a transformative growth phase, as industry leaders and emerging brands alike innovate to meet rising consumer demand for advanced hair styling solutions. Valued at USD 7.1 billion in 2025, the market is projected to reach USD 12.4 billion by 2035, registering a compound annual growth rate (CAGR) of 5.7% over the forecast period.
Between 2025 and 2030, the market is set to rise steadily…
More Releases for Retina
Visual Prosthesis Market | Bionic Vision, Nano Retina, PIXIUM VISION, Retina Imp …
The global visual prosthesis market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the visual prosthesis market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth of the…
Artificial Retina Market Revenue 2019: Nano-Retina, Second Sights
Product innovation is a key artificial retina market trend. The ophthalmic industry has become more competitive over the last few years. Established ophthalmic product categories have become more mature, in turn offering low level of market opportunity for players. Most companies are emphasizing on price level strategy in order to enhance their business presence worldwide. However, the pricing trend could potentially benefit the company on a shorter scale during the…
Artificial Retina Market Key Players – Second Sight, Nano Retina, Retina Impla …
Artificial Retina manufacturers are making huge financial investments in R&D which is leading to new and innovative product development resulting in driving the growth for the market in turn. According to a recent study report published by the Market Research Future, The Global Market of Artificial Retina is growing steadily and is expected to continue its growth soon. Global Artificial Retina Market is expected to grow to US$ 102.9 million…
Artificial Retina Market 2018: Advancement with Key Player – Second Sight, Nan …
Artificial Retina is new hope for blind people and helps blind person to see objects. Artificial retina is placed either in the internal surface of the retina or outer surface of retina. There are around 1.5 million people suffering from retinitis pigmentosa which ultimately causes blindness. Approximately, 280 million people with visual impairment and about 40 million people are completely blind.
Global Artificial Retina Market - Key Players
Some of the…
Artificial Retina Market Insights With Key Players Nano-Retina, Second Sights, a …
Artificial retina market is a major breakthrough in medical devices industry, wherein many universities and leading medical devices companies are conducting research to offer vision to over 285 million visually impaired population worldwide. These devices are mainly nanorod carbon nanotube biomimetic films along with accessory devices such as transmitter and video processing unit (VPU). As such progressive development towards artificial retina is expected to create high ROI for engaged…
Artificial Retina Market Unique Scenario by Key Vendors Like: Second Sight, Nano …
Global Market for Artificial Retina is growing steady and expected to continue its growth near future. Global Artificial Retina Market is expected to grow US$ 102.9 million by 2023 at CAGR of 2.1%.
Global Artificial Retina Market - Key Players
Some of the key players in this market are:
Second Sight (US)
Nano Retina (Israel)
Retina Implant AG (Germany)
Pixium Vision (France)
Bionic Vision Australia
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/2812
Global Artificial Retina Market - Segments
Global Artificial Retina…